Search clinical trials for: Recurrent PSA-only prostate cancer following prostatectomy

Total 95615 results

NYU Langone Health
Blue Earth Diagnostics

Recruiting

Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

Prostate Cancer

United States
Andrew J. Armstrong, MD

Completed

A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)

Prostate Cancer

United States
RTOG Foundation, Inc.
Pfizer; Astellas Pharma Inc

Active, not recruiting

A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery (STEEL)

Prostate Cancer

United States, Canada
Sidney Kimmel Comprehensive Cancer Center at Johns...
AstraZeneca

Active, not recruiting

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Prostate

United States
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy

Prostate Cancer

United States
Martini-Klinik am UKE GmbH
Universitätsklinikum Hamburg-Eppendorf

Recruiting

Prospective Trial: Myocardial Injury After Noncardiac Surgery (MINS) Following Radical Prostatectomy

Myocardial Injury

Germany
Emory University
National Cancer Institute (NCI)

Recruiting

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Biochemically Recurrent Prostate Carcinoma | Prostate Adenocarcinoma

United States
Ankara University

Not yet recruiting

Use of Indocyanine Green in Robotic Prostate Surgeries

Erectile Dysfunction Following Radical Prostatectomy | Prostate Cancer Adenocarcinoma
University of Miami
Integra LifeSciences Corporation

Recruiting

Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy (HAMMER)

Prostate Cancer | Erectile Dysfunction Following Radical Prostatectomy

United States
University Hospital Inselspital, Berne
University of Bern; Debiopharm International SA; Werner und Hedy Berger-Janser...

Recruiting

Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy (HypoFocal SRT)

Recurrent Prostate Cancer

Switzerland
Wake Forest University Health Sciences

Recruiting

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Prostate Cancer | Pain Management | Opioid Use

United States
Biozeus Biopharmaceutical S.A.

Recruiting

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

Erectile Dysfunction | Prostate Cancer | Radical Prostatectomy | Erectile Dysfunction Following Radical Prostatectomy

Brazil
University Health Network, Toronto

Recruiting

Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer (MIDAS-Prostate)

Prostate Cancer

Canada
University Hospital of Patras

Recruiting

Recalled International Index of Erectile Function-5 Collected Post Prostatectomy in Assessing Preop Erectile Function

Erectile Dysfunction Following Radical Prostatectomy

Greece
Ankara University

Recruiting

Retzius-sparing Technique in Robotic-assisted Radical Prostatectomy

Prostate Adenocarcinoma | Urinary Incontinence,Stress | Cancer of Prostate | Erectile Dysfunction Following Radical Prostatectomy

Turkey
Tampere University Hospital
Tampere University

Not yet recruiting

Targeted Radiotherapy for Recurrent Prostate Cancer (TASTEPRO)

Prostate Cancer Recurrence After Radical Prostatectomy

Finland
Azienda Ospedaliero-Universitaria Careggi

Recruiting

PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE (PSICHE)

Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Biochemical Relapse Fo Malignant Neoplasm of Prostate

Italy
Prof. Dr. med. Christian Gratzke
Merck Sharp & Dohme LLC

Recruiting

SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy (Pembro-SRT)

Urologic Cancer | Biochemical Recurrence of Malignant Neoplasm of Prostate

Germany
Lawson Health Research Institute
Cancer Care Ontario; Centre for Probe Development and Commercialization

Recruiting

PSMA-PET Registry for Recurrent Prostate Cancer (PREP)

Recurrent Prostate Cancer

Canada
Proton Collaborative Group
University of Florida Health

Recruiting

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Prostate Cancer

United States
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | Endometrial Adenocarcinoma | Endometrioid Adenocarcinoma

United States, Canada
Memorial Sloan Kettering Cancer Center

Terminated

A Study of Olaparib and Durvalumab in Prostate Cancer

Prostate Cancer

United States
Guy's and St Thomas' NHS Foundation Trust

Completed

Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard Questionnaires (SMACS)

Prostate Cancer | Incontinence | Erectile Dysfunction Following Radical Prostatectomy

United Kingdom
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy (PSMA SRT)

Recurrent Prostate Carcinoma

United States
Anhui Provincial Hospital

Active, not recruiting

Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model (RPWPB)

Prostate Cancer

China
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Radiation Therapy (Hypofractionated Proton Beam Therapy or IMRT) for the Treatment of Recurrent, Oligometastatic Prostate Cancer Following Primary Localized Treatment

Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Recurrent Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Oligometastatic Prostate Carcinoma

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Terminated

Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

PSMA PET Imaging of Recurrent Prostate Cancer

Prostate Cancer | Prostate Adenocarcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Prostate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8

United States
Memorial Sloan Kettering Cancer Center
Ferring Pharmaceuticals

Active, not recruiting

Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy

Metastatic Castration Sensitive Prostate Cancer

United States
AdventHealth
Integra LifeSciences Corporation

Withdrawn

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

Prostate Cancer | Prostatectomy | Incontinence, Urinary | Erectile Dysfunction Following Radical Prostatectomy

United States
Wake Forest University Health Sciences
Samaritan Biologics

Withdrawn

Evaluating Return to Continence and Potency Following Radical Prostatectomy

Prostate Cancer

United States
Medical University of Vienna

Active, not recruiting

Salvage Lymph Node Dissection in Prostate Cancer Patients With Recurrence After Radical Prostatectomy

Prostate Cancer Recurrent

Austria
Biozeus Biopharmaceutical S.A.
Azidus Brasil Scientific Research and Development Ltda

Completed

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

Erectile Dysfunction | Prostate Cancer | Radical Prostatectomy | Erectile Dysfunction Following Radical Prostatectomy

Brazil
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; Southwest Oncology Group

Completed

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

Prostate Cancer

United States, Canada
UNICANCER

Completed

Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery (CARLHA)

Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy

France
Memorial Sloan Kettering Cancer Center
University of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaborators

Completed

3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
Pfizer

Terminated

Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy

Erectile Dysfunction | Penile Cancer | Radical Prostatectomy

United States
RhoVac APS

Active, not recruiting

Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer (BRaVac)

Prostate Cancer Recurrent

Sweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
Progenics Pharmaceuticals, Inc.

Completed

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer (OSPREY)

Prostate Cancer

United States, Canada
Stanford University

Completed

Quality of Life Following Radical Prostatectomy

Prostatic Neoplasms | Prostate Cancer

United States
NCIC Clinical Trials Group
National Cancer Institute (NCI); Southwest Oncology Group

Completed

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

Prostate Cancer

Canada
Progenics Pharmaceuticals, Inc.

Completed

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)

Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer Metastatic

United States, Canada
Johns Hopkins University

Completed

Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy (ERECT)

Erectile Dysfunction | Prostate Cancer

United States
Kantonsspital Winterthur KSW

Terminated

Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial

Erectile Dysfunction Following Radical Prostatectomy

Switzerland
Rabin Medical Center

Unknown

The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical Prostatectomy

Urinary Incontinence | Erectile Dysfunction | Prostate Cancer

Israel
Johns Hopkins University

Terminated

PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (PREVENTER)

Prostate Cancer | Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis | Lymphocele After Surgical Procedure

United States
Benaroya Research Institute
Virginia Mason Hospital/Medical Center

Unknown

Use of Pedometer Following Radical Prostatectomy

Prostate Cancer | Ambulation Difficulty

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Completed

Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy

Adenocarcinoma of the Prostate

United States
Case Comprehensive Cancer Center
The Cleveland Clinic; University Hospitals Cleveland Medical Center

Terminated

Improving Erectile Function and Quality of Life After Prostate Cancer Treatment

Erectile Dysfunction | Prostate Cancer | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Following Simple Prostatectomy

United States

Search clinical trials for: Recurrent PSA-only prostate cancer following prostatectomy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations